FHTX Foghorn Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$2,02
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,7952-Wochen-Tief
$7,6152-Wochen-Hoch
Marktkapitalisierung (MRQ)
$119M
P/E (TTM)
-2.0
EPS (TTM)
$-0.99
Umsatz (TTM)
$37M
Ihre Abzeichen
52W-Spanne
$2–$8
Analystenbewertung
BUY
Kursziel
$11
P/E
-2.0
ROE
81.9%
Nettogewinnmarge
-175.8%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
FHTX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.02
Marktkapitalisierung (MRQ)
$119M
P/E (TTM)
-2.0
EPS (TTM)
$-0.99
Umsatz (TTM)
$37M
ROE (TTM)
81.9%
52W-Spanne
$2–$8
FHTX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$31M2020-12-31 → 2025-12-31
EPS$-1.182020-12-31 → 2025-12-31
Freier Cashflow$-86M2021-12-31 → 2025-12-31
Nettogewinnmarge-175.8%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | FHTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -2.05-Jahres-Durchschnitt ≈-4.2 | ≈-4.2 | · | · | |
| P/S (TTM) | 3.25-Jahres-Durchschnitt ≈10.8 | ≈10.8 | 48.5 | Unterbewertet | |
| K/B (MRQ) | -1.55-Jahres-Durchschnitt ≈592.3 | ≈592.3 | · | · | |
| Kurs / FCF (TTM) | -1.45-Jahres-Durchschnitt ≈-1.8 | ≈-1.8 | · | · | |
| Kurs / Cashflow (TTM) | -1.45-Jahres-Durchschnitt ≈-1.8 | ≈-1.8 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | FHTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -198.0%5-Jahres-Durchschnitt ≈-1859.2% | ≈-1859.2% | -680.6% | Spitzenklasse | |
| EBITDA-Marge (TTM) | -192.5%5-Jahres-Durchschnitt ≈-1799.9% | ≈-1799.9% | -664.4% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -175.8%5-Jahres-Durchschnitt ≈-1831.9% | ≈-1831.9% | -722.9% | Spitzenklasse | |
| ROA (TTM) | -30.1%5-Jahres-Durchschnitt ≈-28.3% | ≈-28.3% | -33.9% | Spitzenklasse | |
| ROE (TTM) | 81.9%5-Jahres-Durchschnitt ≈-107.5% | ≈-107.5% | -50.1% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | FHTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 3.45-Jahres-Durchschnitt ≈4.2 | ≈4.2 | 4.7 | Geringe Liquidität | |
| Quick Ratio | 1.45-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 4.5 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | FHTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 36.8%5-Jahres-Durchschnitt ≈329.0% | ≈329.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 17.1%5-Jahres-Durchschnitt ≈168.3% | ≈168.3% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 135.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | FHTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.1 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$291.6K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
16.3%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 11, 2026 | $-0.10 | $-0.26 | 61.7% |
| 31. März 2026 | Mai 12, 2026 | $-0.29 | $-0.31 | 6.8% |
| 31. Dezember 2025 | $-0.34 | $-0.25 | -34.8% | |
| 30. September 2025 | $-0.25 | $-0.34 | 26.4% | |
| 30. Juni 2025 | $-0.28 | $-0.37 | 23.4% | |
| 31. März 2025 | $-0.30 | $-0.35 | 14.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $31M | $23M | $34M | $19M | $1M | $430.0K | |
| R&D Expense | $85M | $95M | $110M | $106M | $80M | $58M | |
| SG&A Expense | $28M | $28M | $32M | $31M | $22M | $11M | |
| Operating Expenses | $117M | $125M | $142M | $136M | $102M | $69M | |
| Operating Income | $-86M | $-103M | $-108M | $-117M | $-101M | $-69M | |
| Interest Expense | · | · | · | · | $2M | $979.0K | |
| Other Non-op | $12M | $16M | $14M | $8M | $2M | $-269.0K | |
| Pretax Income | · | $-87M | $-94M | $-109M | · | · | |
| Income Tax | $0 | $0 | $4M | $0 | · | $0 | |
| Net Income | $-74M | $-87M | $-98M | $-109M | $-101M | $-69M | |
| EPS (Basic) | $-1.18 | $-1.58 | $-2.34 | $-2.62 | $-2.73 | $-6.23 | |
| EPS (Diluted) | $-1.18 | $-1.58 | $-2.34 | $-2.62 | $-2.73 | $-6.23 | |
| Shares (Basic) | 62,980,959 | 54,899,432 | 41,974,484 | 41,591,433 | 37,171,147 | 11,046,802 | |
| Shares (Diluted) | 62,980,959 | 54,899,432 | 41,974,484 | 41,591,433 | 37,171,147 | 11,046,802 | |
| EBITDA | $-83M | $-100M | $-104M | $-114M | $-98M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $81M | $55M | $80M | $52M | $101M | $93M | |
| Prepaid Expense | $3M | $6M | $6M | $6M | $5M | $5M | |
| Current Assets | $163M | $250M | $240M | $351M | $460M | $191M | |
| PP&E (Net) | · | · | · | · | · | $20M | |
| PP&E (Gross) | · | · | · | · | · | $22M | |
| Accum. Depreciation | · | · | · | · | · | $2M | |
| Other Non-current Assets | $4.0K | $68.0K | $1M | $2M | $2M | $842.0K | |
| Total Assets | $198M | $284M | $286M | $405M | $520M | $256M | |
| Accounts Payable | $4M | $4M | $6M | $5M | $4M | $4M | |
| Accrued Liabilities | $11M | $9M | $9M | $11M | $10M | $9M | |
| Current Liabilities | $60M | $67M | $58M | $55M | $49M | $19M | |
| Capital Leases | $40M | $28M | $37M | $46M | $51M | $58M | |
| Other Non-current Liabilities | $556.0K | $0 | $0 | $29.0K | $143.0K | $0 | |
| Total Liabilities | $307M | $330M | $363M | $405M | $423M | $109M | |
| Long-term Debt | · | · | · | · | · | $20M | |
| Total Debt | · | · | · | · | $0 | · | |
| Common Stock | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $524M | $513M | $395M | $377M | $361M | $309M | |
| Retained Earnings | $-632M | $-558M | $-472M | $-373M | $-264M | $-163M | |
| AOCI | $24.0K | $135.0K | $-826.0K | $-4M | $-10.0K | $-7.0K | |
| Stockholders' Equity | $-108M | $-46M | $-77M | $112.0K | $97M | $146M | |
| Liabilities + Equity | $198M | $284M | $286M | $405M | $520M | $256M | |
| Shares Outstanding | 56,657,329 | 55,594,131 | 42,282,040 | 41,803,436 | 41,299,720 | 36,790,946 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $1M | |
| Stock-based Comp | $10M | $12M | $16M | $14M | $8M | $3M | |
| Other Non-cash | $-26M | $-29M | $-39M | $285M | $39M | · | |
| Operating Cash Flow | $-86M | $-100M | $-118M | $194M | $-50M | $-31M | |
| CapEx | $50.0K | $906.0K | $1M | $1M | $3M | $16M | |
| Investing Cash Flow | $112M | $-30M | $144M | $-244M | $36M | $-109M | |
| Stock Issued | · | $103M | $0 | · | · | · | |
| Net Stock Activity | · | $103M | · | · | · | · | |
| Financing Cash Flow | $1M | $105M | $2M | $2M | $22M | $217M | |
| Taxes Paid | $9.0K | $860.0K | $4M | · | · | · | |
| Free Cash Flow | $-86M | $-101M | $-119M | $192M | $-54M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -279.5% | -454.3% | -315.9% | -609.2% | -7637.1% | · | |
| Net Margin | -240.3% | -383.2% | -288.2% | -566.3% | -7681.6% | · | |
| Pretax Margin | · | -383.2% | -275.8% | · | · | · | |
| EBITDA Margin | -268.7% | -440.5% | -305.8% | -591.9% | -7392.5% | · | |
| ROA | -30.8% | -30.4% | -28.5% | -23.5% | · | · | |
| ROE | 80.2% | 234.7% | 146.3% | -891.2% | · | · | |
| ROIC | · | 225.5% | 146.1% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 3.7 | 4.1 | 6.4 | · | · | |
| Quick Ratio | 1.4 | 0.8 | 1.4 | 0.9 | · | · | |
| Interest Coverage | · | · | · | · | -52.9 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.0 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.92 | $-0.82 | $-1.83 | $0.00 | · | · | |
| Revenue / Share | $0.49 | $0.41 | $0.81 | $0.46 | $0.04 | · | |
| Cash Flow / Share | $-1.37 | $-1.83 | $-2.81 | $4.66 | $-1.35 | · | |
| Cash / Share | $1.43 | $1.00 | $1.90 | $1.25 | · | · | |
| EPS (TTM) | $-1.18 | $-1.58 | $-2.34 | $-2.62 | $-2.73 | $-6.23 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 36.8% | -33.8% | 77.6% | 1357.8% | 206.7% | · | |
| Revenue CAGR 3Y | 17.1% | 157.8% | 329.9% | · | · | · | |
| Revenue CAGR 5Y | 135.1% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $23M | $34M | $19M | $1M | $430.0K | |
| Net Income TTM | $-74M | $-87M | $-98M | $-109M | $-101M | $-69M | |
| Market Cap | $306M | $262M | $273M | $267M | · | · | |
| P/E | -4.6 | -3.0 | -2.8 | -2.4 | -8.4 | -3.3 | |
| P/S | 9.9 | 11.6 | 8.0 | 13.9 | · | · | |
| P/B | -2.8 | -5.8 | -3.5 | 2381.3 | · | · | |
| P / Tangible Book | · | · | · | 2381.3 | 9.8 | 5.1 | |
| P / Cash Flow | -3.6 | -2.6 | -2.3 | 1.4 | · | · | |
| P / FCF | -3.6 | -2.6 | -2.3 | 1.4 | · | · | |
| Earnings Yield | -21.9% | -33.5% | -36.3% | -41.1% | -11.9% | -30.7% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $3M | $9M | $8M | $8M | $6M | $3M | $8M | $7M | $5M | $6M | $17M | $6M | $5M | $4M | $7M | |
| R&D Expense | $19M | $18M | $22M | $20M | $22M | $22M | $21M | $25M | $24M | $26M | $24M | $26M | $29M | $30M | $28M | $27M | |
| SG&A Expense | $6M | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | $8M | $7M | $8M | $8M | $9M | $8M | $8M | |
| Operating Expenses | $25M | $25M | $33M | $27M | $29M | $29M | $27M | $32M | $34M | $33M | $31M | $35M | $38M | $39M | $36M | $35M | |
| Operating Income | $-9M | $-22M | $-24M | $-19M | $-21M | $-23M | $-24M | $-24M | $-27M | $-28M | $-25M | $-17M | $-32M | $-33M | $-32M | $-28M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-op | $2M | $2M | $2M | $3M | $3M | $4M | $5M | $5M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | $2M | |
| Pretax Income | · | · | · | · | · | · | · | $-19M | $-23M | $-25M | $-22M | $-14M | $-29M | $-30M | $-29M | $-26M | |
| Income Tax | · | · | · | · | · | · | · | $0 | $0 | $0 | $2M | $738.0K | $942.0K | $560.0K | $0 | $0 | |
| Net Income | $-7M | $-20M | $-22M | $-16M | $-18M | $-19M | $-20M | $-19M | $-23M | $-25M | $-24M | $-14M | $-29M | $-30M | $-29M | $-26M | |
| EPS (Basic) | $-0.10 | $-0.29 | $-0.35 | $-0.25 | $-0.28 | $-0.30 | $-0.23 | $-0.31 | $-0.45 | $-0.59 | $-0.57 | $-0.34 | $-0.70 | $-0.73 | $-0.69 | $-0.62 | |
| EPS (Diluted) | $-0.10 | $-0.29 | $-0.35 | $-0.25 | $-0.28 | $-0.30 | $-0.23 | $-0.31 | $-0.45 | $-0.59 | $-0.57 | $-0.34 | $-0.70 | $-0.73 | $-0.69 | $-0.62 | |
| Shares (Basic) | 70,629,419 | 69,540,075 | · | 63,029,293 | 62,978,219 | 62,848,673 | · | 62,602,848 | 51,580,310 | 42,428,813 | · | 42,025,938 | 41,825,555 | 41,811,087 | · | 41,672,621 | |
| Shares (Diluted) | 70,629,419 | 69,540,075 | · | 63,029,293 | 62,978,219 | 62,848,673 | · | 62,602,848 | 51,580,310 | 42,428,813 | · | 42,025,938 | 41,825,555 | 41,811,087 | · | 41,672,621 | |
| EBITDA | $-9M | $-21M | · | $-18M | $-20M | $-22M | · | $-23M | $-26M | $-27M | · | $-16M | $-31M | $-32M | · | $-27M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $68M | $88M | $81M | $89M | $73M | $61M | $55M | $58M | $139M | $79M | $80M | $70M | $58M | $51M | $52M | $88M | |
| Prepaid Expense | $2M | $3M | $3M | $3M | $4M | $5M | $6M | $4M | $4M | $5M | $6M | $6M | $6M | $5M | $6M | $4M | |
| Current Assets | $170M | $188M | $163M | $184M | $204M | $225M | $250M | $271M | $290M | $212M | $240M | $265M | $290M | $321M | $351M | $378M | |
| Other Non-current Assets | $3.0K | $3.0K | $4.0K | $5.0K | $6.0K | $24.0K | $68.0K | $848.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| Total Assets | $203M | $222M | $198M | $205M | $226M | $259M | $284M | $308M | $329M | $255M | $286M | $313M | $340M | $373M | $405M | $434M | |
| Accounts Payable | $3M | $3M | $4M | $3M | $3M | $4M | $4M | $3M | $5M | $6M | $6M | $6M | $7M | $7M | $5M | $5M | |
| Accrued Liabilities | $8M | $7M | $11M | $10M | $9M | $6M | $9M | $11M | $6M | $6M | $9M | $9M | $8M | $9M | $11M | $10M | |
| Current Liabilities | $51M | $64M | $60M | $85M | $78M | $71M | $67M | $57M | $51M | $52M | $58M | $52M | $57M | $56M | $55M | $55M | |
| Capital Leases | $40M | $40M | $40M | $16M | $18M | $26M | $28M | $30M | $33M | $34M | $37M | $39M | $40M | $43M | $46M | $46M | |
| Other Non-current Liabilities | $350.0K | $453.0K | $556.0K | $656.0K | $757.0K | $856.0K | $0 | · | · | · | · | $0 | $0 | $0 | $29.0K | $58.0K | |
| Total Liabilities | $284M | $299M | $307M | $295M | $303M | $320M | $330M | $337M | $343M | $352M | $363M | $371M | $389M | $397M | $405M | $410M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $579M | $576M | $524M | $521M | $518M | $515M | $513M | $510M | $506M | $400M | $395M | $392M | $386M | $382M | $377M | $373M | |
| Retained Earnings | $-660M | $-652M | $-632M | $-611M | $-595M | $-577M | $-558M | $-539M | $-520M | $-497M | $-472M | $-447M | $-433M | $-404M | $-373M | $-344M | |
| AOCI | $-134.0K | $-133.0K | $24.0K | $24.0K | $-44.0K | $14.0K | $135.0K | $360.0K | $-338.0K | $-497.0K | $-826.0K | $-2M | $-3M | $-3M | $-4M | $-5M | |
| Stockholders' Equity | $-81M | $-76M | $-108M | $-90M | $-77M | $-62M | $-46M | $-28M | $-14M | $-97M | $-77M | $-57M | $-49M | $-25M | $112.0K | $24M | |
| Liabilities + Equity | $203M | $222M | $198M | $205M | $226M | $259M | $284M | $308M | $329M | $255M | $286M | $313M | $340M | $373M | $405M | $434M | |
| Shares Outstanding | 58,714,272 | 58,710,490 | 56,657,329 | 56,542,877 | 55,803,195 | 55,721,340 | 55,594,131 | 55,593,131 | 55,328,655 | 42,585,616 | 42,282,040 | 42,217,126 | 41,852,438 | 41,824,758 | 41,803,436 | 41,799,368 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $200.0K | $238.0K | $705.0K | $900.0K | $900.0K | $827.0K | $785.0K | $700.0K | $800.0K | $835.0K | $892.0K | $900.0K | $800.0K | $859.0K | $810.0K | $900.0K | |
| Stock-based Comp | $3M | $2M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $5M | $4M | $4M | |
| Other Non-cash | · | $-8M | · | · | · | $-9M | · | · | · | $-8M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-18M | $-25M | $-22M | $-19M | $-21M | $-24M | $-25M | $-21M | $-26M | $-29M | $-28M | $-27M | $-32M | $-31M | $-29M | $-20M | |
| CapEx | $50.0K | $0 | $0 | $0 | $22.0K | $28.0K | $479.0K | $309.0K | $17.0K | $101.0K | $37.0K | $82.0K | $469.0K | $636.0K | $269.0K | $330.0K | |
| Investing Cash Flow | $-3M | $-18M | $13M | $36M | $34M | $29M | $22M | $-61M | $-18M | $27M | $37M | $38M | $39M | $30M | $-7M | $46M | |
| Stock Issued | $0 | $50M | · | $0 | $0 | $0 | · | $0 | · | · | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $50M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-22.0K | $50M | $581.0K | $49.0K | $254.0K | $139.0K | $4.0K | $1M | $103M | $1M | $186.0K | $1M | $103.0K | $102.0K | $16.0K | $333.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | $-81M | $60M | $-1M | · | $13M | $7M | $-2M | · | $26M | |
| Taxes Paid | $0 | $2.0K | $1.0K | $0 | $4.0K | $4.0K | $47.0K | $59.0K | $705.0K | $49.0K | $865.0K | $996.0K | $2M | $0 | · | $0 | |
| Free Cash Flow | · | $-25M | · | · | · | $-24M | · | · | · | $-29M | · | · | · | $-32M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -54.8% | -660.3% | · | -226.9% | -279.2% | -385.0% | · | -305.5% | -386.6% | -558.3% | · | -97.7% | -572.4% | -627.6% | · | -426.0% | |
| Net Margin | -44.7% | -608.4% | · | -194.4% | -237.3% | -316.4% | · | -244.9% | -333.6% | -495.4% | · | -82.1% | -526.6% | -574.3% | · | -388.4% | |
| Pretax Margin | · | · | · | · | · | · | · | -244.9% | -333.6% | -495.4% | · | -77.8% | -509.8% | -563.7% | · | · | |
| EBITDA Margin | -53.5% | -653.0% | · | -215.9% | -267.3% | -371.1% | · | -296.5% | -375.0% | -541.8% | · | -92.6% | -558.1% | -611.4% | · | -412.4% | |
| ROA | -3.4% | -8.3% | · | -6.2% | -6.5% | -7.3% | · | -6.2% | -6.9% | -8.0% | · | -3.8% | -7.4% | -7.1% | · | -8.3% | |
| ROE | 9.1% | 28.8% | · | 26.9% | 39.4% | 23.7% | · | 44.6% | 72.2% | 41.0% | · | 86.8% | 3432.7% | -127.5% | · | -48.9% | |
| ROIC | · | · | · | · | · | · | · | 84.3% | 185.9% | 28.9% | · | 31.4% | 67.1% | 138.1% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.9 | · | 2.2 | 2.6 | 3.2 | · | 4.8 | 5.7 | 4.1 | · | 5.1 | 5.1 | 5.7 | · | 6.8 | |
| Quick Ratio | 1.3 | 1.4 | · | 1.0 | 0.9 | 0.9 | · | 1.0 | 2.7 | 1.5 | · | 1.4 | 1.0 | 0.9 | · | 1.6 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.38 | $-1.30 | · | $-1.59 | $-1.37 | $-1.11 | · | $-0.51 | $-0.26 | $-2.29 | · | $-1.36 | $-1.18 | $-0.59 | · | $0.58 | |
| Revenue / Share | $0.23 | $0.05 | · | $0.13 | $0.12 | $0.09 | · | $0.12 | $0.13 | $0.12 | · | $0.42 | $0.13 | $0.13 | · | $0.16 | |
| Cash Flow / Share | · | $-0.36 | · | · | · | $-0.38 | · | · | · | $-0.69 | · | · | · | $-0.75 | · | · | |
| Cash / Share | $1.16 | $1.49 | · | $1.58 | $1.30 | $1.10 | · | $1.04 | $2.51 | $1.86 | · | $1.67 | $1.38 | $1.21 | · | $2.10 | |
| EPS (TTM) | $-0.99 | $-1.17 | · | $-1.06 | $-1.12 | $-1.29 | · | $-1.92 | $-1.95 | $-2.20 | · | $-2.46 | $-2.74 | $-2.70 | · | $-2.70 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $37M | $28M | · | $25M | $24M | $24M | · | $26M | $35M | $34M | · | $33M | $22M | $21M | · | $16M | |
| Net Income TTM | $-65M | $-75M | · | $-72M | $-75M | $-80M | · | $-91M | $-86M | $-93M | · | $-103M | $-115M | $-112M | · | $-109M | |
| Market Cap | $287M | $281M | · | $276M | $262M | $203M | · | $518M | $318M | $286M | · | $211M | $295M | $259M | · | $359M | |
| P/E | -4.9 | -4.1 | · | -4.6 | -4.2 | -2.8 | · | -4.8 | -2.9 | -3.0 | · | -2.0 | -2.6 | -2.3 | · | -3.2 | |
| P/S | 7.8 | 9.9 | · | 11.3 | 10.8 | 8.7 | · | 20.3 | 9.0 | 8.4 | · | 6.5 | 13.6 | 12.6 | · | 22.8 | |
| P/B | -3.5 | -3.7 | · | -3.1 | -3.4 | -3.3 | · | -18.3 | -22.2 | -2.9 | · | -3.7 | -6.0 | -10.5 | · | 14.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 14.7 | |
| P / Cash Flow | · | -11.1 | · | · | · | -8.5 | · | · | · | -9.7 | · | · | · | -8.3 | · | · | |
| Earnings Yield | -20.3% | -24.5% | · | -21.7% | -23.8% | -35.3% | · | -20.6% | -33.9% | -32.8% | · | -49.2% | -38.9% | -43.5% | · | -31.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $31M | $23M | $34M | $19M | $1M |
| Betriebsgewinnmarge % | -279.5% | -454.3% | -315.9% | -609.2% | -7637.1% |
| Nettoergebnis | $-74M | $-87M | $-98M | $-109M | $-101M |
| Verwässerte EPS | $-1.18 | $-1.58 | $-2.34 | $-2.62 | $-2.73 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.7 | 3.7 | 4.1 | 6.4 | · |
| Quick Ratio | 1.4 | 0.8 | 1.4 | 0.9 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-86M | $-101M | $-119M | $192M | $-54M |
Institutionelle Eigentümer (13F) 106 Einreicher · $229.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
106
Gehaltener Wert
$229.3M
Neue Positionen
15
Geschlossene Positionen
14
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 15 (-7 vs. Vorquartal) | 14 (+5 vs. Vorquartal) | 38 (-1 vs. Vorquartal) | 26 (+6 vs. Vorquartal) | +940K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Flagship Pioneering, LLC | $61.849.706 | 12.674.120 | 26,98% | Aktien |
| BVF INC/IL | $28.508.960 | 5.842.000 | 12,44% | Aktien |
| FMR LLC | $27.845.075 | 5.705.958 | 12,15% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $21.444.511 | 4.394.367 | 9,35% | Aktien |
| BlackRock, Inc. | $12.818.939 | 2.626.832 | 5,59% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $12.151.093 | 2.489.978 | 5,30% | Aktien |
| VANGUARD GROUP INC | $10.416.557 | 1.928.992 | 4,54% | Aktien |
| Euclidean Capital LLC | $7.679.954 | 1.573.761 | 3,35% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.293.702 | 1.494.611 | 3,18% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.446.091 | 910.866 | 1,94% | Aktien |
| Siren, L.L.C. | $3.517.114 | 720.720 | 1,53% | Aktien |
| STATE STREET CORP | $3.403.649 | 697.469 | 1,48% | Aktien |
| AMERIPRISE FINANCIAL INC | $2.726.383 | 558.685 | 1,19% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.844.328 | 377.936 | 0,80% | Aktien |
| Candriam S.C.A. | $1.529.700 | 313.765 | 0,67% | Aktien |
| NORTHERN TRUST CORP | $1.511.703 | 309.775 | 0,66% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.490.518 | 305.434 | 0,65% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.485.628 | 304.432 | 0,65% | Aktien |
| Birchview Capital, LP | $1.375.853 | 281.937 | 0,60% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.290.379 | 264.422 | 0,56% | Aktien |
| Qube Research & Technologies Ltd | $992.084 | 203.296 | 0,43% | Aktien |
| Woodline Partners LP | $986.468 | 202.145 | 0,43% | Aktien |
| B Group, Inc. | $976.000 | 200.000 | 0,43% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $855.981 | 175.406 | 0,37% | Aktien |
| GOLDMAN SACHS GROUP INC | $801.569 | 164.256 | 0,35% | Aktien |
| CITADEL ADVISORS LLC | $775.051 | 158.822 | 0,34% | Aktien |
| Squarepoint Ops LLC | $636.088 | 130.346 | 0,28% | Aktien |
| DAFNA Capital Management LLC | $545.872 | 111.859 | 0,24% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $535.731 | 109.781 | 0,23% | Aktien |
| SCS Capital Management LLC | $522.062 | 106.980 | 0,23% | Aktien |
| MORGAN STANLEY | $449.429 | 92.096 | 0,20% | Aktien |
| Palumbo Wealth Management LLC | $447.687 | 91.739 | 0,20% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $437.248 | 89.600 | 0,19% | Aktien |
| Bank of New York Mellon Corp | $387.253 | 79.355 | 0,17% | Aktien |
| Invesco Ltd. | $381.298 | 78.135 | 0,17% | Aktien |
| DIADEMA PARTNERS LP | $326.511 | 66.908 | 0,14% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $323.247 | 66.239 | 0,14% | Aktien |
| Nuveen, LLC | $317.390 | 65.039 | 0,14% | Aktien |
| Lynx1 Capital Management LP | $300.549 | 61.588 | 0,13% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $283.499 | 58.094 | 0,12% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $261.124 | 53.509 | 0,11% | Aktien |
| Verdad Advisers, LP | $259.767 | 53.231 | 0,11% | Aktien |
| Persistent Asset Partners Ltd | $228.735 | 46.872 | 0,10% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $224.358 | 45.975 | 0,10% | Aktien |
| RHUMBLINE ADVISERS | $193.152 | 39.582 | 0,08% | Aktien |
| DEUTSCHE BANK AG\ | $178.301 | 36.537 | 0,08% | Aktien |
| Jump Financial, LLC | $177.549 | 36.383 | 0,08% | Aktien |
| WELLS FARGO & COMPANY/MN | $172.268 | 35.301 | 0,08% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $142.253 | 29.760 | 0,06% | Aktien |
| BANK OF AMERICA CORP /DE/ | $127.383 | 26.103 | 0,06% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Flagship Ventures Fund V, L.P., Flagship Ventures Fund V General Partner LLC, Flagship Ventures Opportunities Fund I, L.P., Flagship Ventures Opportunities Fund I General Partner LLC, Flagship Pioneering Special Opportunities Fund II, L.P., Flagship Pioneering Special Opportunities Fund II General Partner LLC, Flagship Pioneering Fund VII, L.P., Flagship Pioneering Fund VII General Partner LLC, Flagship Pioneering, LLC, Noubar Afeyan | 13. Januar 2026 | 27,20% | Änderung | · | SEC |
| Flagship Ventures Fund V, L.P. (2), Flagship Ventures Fund V General Partner LLC (2), Flagship Ventures Opportunities Fund I, L.P. (2), Flagship Ventures Opportunities Fund I General Partner LLC (2), Flagship Pioneering Special Opportunities Fund II, L.P. (2), Flagship Pioneering Special Opportunities Fund II General Partner LLC (2), Flagship Pioneering Fund VII, L.P. (2), Flagship Pioneering Fund VII General Partner LLC (2), Flagship Pioneering, Inc. (2), Noubar Afeyan (2) ×2 Einreichungen | 24. Mai 2024 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 23 Insider · 11 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Adrian Gottschalk | Chief Executive Officer | 10. April 2026 G | 270.912 | 0 | 0 | $0 |
| Kristian Humer | Chief Financial Officer | 22. Januar 2025 A | · | 0 | 0 | $0 |
| Allan Reine | Chief Financial Officer | 26. Januar 2023 A | 53.784 | 0 | 0 | $0 |
| Anna Rivkin | Chief Business Officer | 30. Januar 2026 A | · | 0 | 0 | $0 |
| Carlos Costa | Chief People Officer | 30. Januar 2026 A | 0 | 0 | 0 | $0 |
| Michael Lacascia | Chief Legal Officer | 30. Januar 2026 A | · | 0 | 0 | $0 |
| Steven F. Bellon | Chief Scientific Officer | 30. Januar 2026 A | 101.957 | 0 | 0 | $0 |
| Alfonso Quintas Cardama | Chief Medical Officer | 30. Januar 2026 A | · | 0 | 0 | $0 |
| Fanny Cavalie | Chief Strategy/Bus Ops Officer | 11. März 2024 S | 75.992 | 0 | 0 | $0 |
| Samuel Agresta | Chief Medical Officer | 16. August 2023 M | 0 | 0 | 0 | $0 |
| Carl Decicco | Chief Scientific Officer | 9. Dezember 2021 M | 362.707 | 0 | 0 | $0 |
| Neil Gallagher | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Stuart Duty | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Michael Mendelsohn | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Scott Biller | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Douglas G. Cole | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Thomas J. Lynch Jr. | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Ian F Smith | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Simba Gill | Direktor | 24. Juni 2026 A | 34.061 | 0 | 0 | $0 |
| Lynne B Parshall | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Adam Koppel | Direktor | 26. Juni 2024 A | · | 0 | 0 | $0 |
| Cigall Kadoch | Direktor | 21. Juni 2022 A | · | 0 | 0 | $0 |
| Ryan D Maynard | · | 23. Februar 2026 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 13 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 49.159 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,04% | 124.539 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 4.209 SH | 2. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 342.513 SH | 11. September 2026 | Täglich |
| IBB · iShares Trust | 0,01% | 236.414 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 209.037 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 39.520 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 17.433 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 880.194 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 10.640 SH | 2. Oktober 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 428.310 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.027.071 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.231 SH | 19. August 2026 | Täglich |
FHTX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 16 Analysten
KAUF
Median-Ziel
$12.00
+494,1%
7 43,8%
Starker Kauf
8 50,0%
Kauf
1 6,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
9 Analysten · 2026-09-20Mittelwert-Ziel $11.44 +466,6%
← Unter allen Zielen
Aktueller Preis $2.02
Tief$9.00
Mittelwert$11.44
Hoch$14.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026